RB1 and glioblastoma: As shown in Figure 3F, the protein expression level of p-ERK was significantly attenuated by treatment with the ERK inhibitor U0126, indicating that the MAPK/ERK pathway was engaged in RB-induced GBM cell G2/M phase arrest.